All News

RheumNow Podcast square

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!

Read Article
RNL, over, microphone

RheumNow Live 2021 Now Available for All

d Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
masks_0.jpg

CDC: Fully Vaccinated Can Shed Masks and Resume Travel

d Jack Cush, MD

The U.S.

Read Article
"Arthritis Mutilans" - worse outcome to chronic inflammatory arthritis is due to 5 disorders: 1) RA 2) Psoriatic arthritis 3) Tophaceous gout 4) polyarticular JIA 5) Multicentric reticulohistiocytosis (Ive never seen this!!) https://t.co/XYmBEW1F0R https://t.co/tGWNG9Aklw

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i #LupusAwarenessMonth https://t.co/apjrwa36dA

Links:

Dr. John Cush RheumNow ( View Tweet)
Increased Methotrexate Liver Disease in Psoriasis https://t.co/sEZajDIkSz

Links:

Dr. John Cush RheumNow ( View Tweet)

RNL 2021 - Assessing Psoriasis: Melodie Young, MSN, ANP-c https://t.co/ZzOnJOtKjz

Links:

Dr. John Cush RheumNow ( View Tweet)

Join us this Tuesday for Tuesday Night Rheumatology focusing on Spondyloarthritis with sessions from Dr. Nigil Haroon, Dr. Artie Kavanaugh, and Dr. Robert Wang. https://t.co/Jr6H0Yg6xs https://t.co/UXx37liLSZ

Links:

Dr. John Cush RheumNow ( View Tweet)
RNL 2021 - Spondyloarthritis Q & A Panel Discussion https://t.co/3oFZNV0XI6

Links:

Dr. John Cush RheumNow ( View Tweet)

New podcast available— BandAids for Rheumatologists. Listen on SoundCloud and wherever podcasts are available. https://t.co/AGROPnfAAi

Links:

Dr. John Cush RheumNow ( View Tweet)

RNL 2021: EULAR 2019 and ACR 2020 RA Treatment Guidelines - Dr. Alan Matsumoto Dr. Alan Matsumoto presents EULAR 2019 and ACR 2020 RA Treatment Guidelines at the 2021 RheumNow Live meeting. https://t.co/1swZIWGWKc

Links:

Dr. John Cush RheumNow ( View Tweet)

Cerecor has launched a c Phase 1b clinical trial (NCT04752371) of the human mAb CERC-007, targeting IL-18, in 12 patients with active adult onset Still’s disease (AOSD). They estimate AOSD affects 3,500 - 7,000 in the US 3,400 - 6,900 pts in Europe https://t.co/DlW1QbXOG0

Links:

Dr. John Cush RheumNow ( View Tweet)

CDC study from 33 sites, 25 states showed vaccine efficacy (against Sx COVID) in HCP was 82% with ONEdose (Pfizer, Moderna) and 94% for TWO doses (same as RCTs). The efficacy of only 1 dose (of a 2 dose COVID vax) is likely to be 70- 82%. https://t.co/uQhUmjSsRd

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Mike Putman - TULIP Trials - Anifrolumab in SLE https://t.co/cqZiulDMFm #LupusAwarenessMonth https://t.co/kNKLUSOKWp

Links:

Dr. John Cush RheumNow ( View Tweet)
Clinical practice data study of 855 Psoriatic arthritis patients. With no differences in treatment, women has worse disease activity score (vs M) (PASDAS 3.5 vs 2.7; p < 0.001). Higher BMI assoc w/ no reaching Low Dz activity in Women, not men. https://t.co/CVAEHhjqCH

Links:

Dr. John Cush RheumNow ( View Tweet)

Worth sharing again-- ACR Updates COVID-19 Vaccine Guidance- April 2021 The ACR COVID-19 Vaccine Clinical Guidance was originally published on 2/8/21 & updated on 3/4/21. On 4/28/21, new recommendations were added. https://t.co/BgrFxCgjRw https://t.co/O7ngEBEX6s

Links:

Dr. John Cush RheumNow ( View Tweet)
Johns Hopkins researchers suggest that treating refractory dermatomyositis with a JAK inhibitor may improve calcinosis. Based on 3 case reports, who had either NXP2 or TIF-1γ refractory DM, all improved their skin, muscle dz and calcinosis. https://t.co/P5k5y0HS6A

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease https://t.co/ps8JeRUtJf https://t.co/Sn6ykG9ZuE

Links:

Dr. John Cush RheumNow ( View Tweet)
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Insurers Bet Big on Bribing Patients https://t.co/Tcip2xODF1 https://t.co/Ieh7yZfurk

Links:

Dr. John Cush RheumNow ( View Tweet)
×